Amanda Vale Catunda

Amanda Vale Catunda

Auto-generated profile, based on publicly available information

Amanda Vale Catunda

Hospital Geral de Fortaleza, Departamento de Neurologia, Fortaleza CE, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2025 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
AVAna Silvia Sobreira Lima Verde
Ana Silvia Sobreira Lima Verde
AMAlessandra Braga Cruz Guedes de Morais
Alessandra Braga Cruz Guedes de Morais
ACAmanda Vale Catunda
Amanda Vale Catunda
JLJoão Igor Dantas Landim
João Igor Dantas Landim
IRIan Silva Ribeiro
Ian Silva Ribeiro
NFNorberto Anízio Ferreira Frota
Norberto Anízio Ferreira Frota
Cerebral amyloid angiopathy (CAA) is a small vessel disease characterized by the deposition of amyloid-beta in small cerebral vessels, which can lead to intracerebral hemorrhages and cognitive impairment. Rare variants, such as cerebral amyloid angiopathy-related inflammation (CAA-ri) and iatrogenic CAA (ICAA), may mimic other neurological conditions and challenge diagnosis in clinical practice. We present three cases that illustrate distinct CAA syndromes, along with CSF biomarker analysis. One patient experienced recurrent hemorrhagic strokes with a history of dural graft, raising concerns about amyloid transmission. Two patients presented with rapidly progressive dementia that fulfilled CAA-ri criteria. All cases exhibited decreased levels of CSF Aβ40 and Aβ42, with one showing elevated p-tau, suggesting comorbid Alzheimer's pathology. Cerebrospinal fluid biomarkers complement neuroimaging in the diagnosis of CAA, aiding in differentiation from other dementias. Early recognition and diagnosis of CAA-ri variants is crucial, because immunotherapy may improve outcomes. Further research is necessary to establish biomarker thresholds and their clinical applicability.